alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**Exhibit 99.1**

 

**CERTIFICATIONPURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

 

In connection with theQuarterly Report of Pace Medical, Inc. (the “Company”) on Form 10-Q for theperiod ending June 30, 2002 as filed with the Securities and ExchangeCommission on the date hereof (the “Report”), I, Ralph Hanson, Chief ExecutiveOfficer and Chief Accounting Officer of the Company, certify, pursuant to 18U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002,that:

 

(1)  The Report fully complies with therequirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934;and

 

(2)  The information contained in the Reportfairly presents, in all material respects, the financial condition and resultof operations of the Company.

 

 
| /s/ Ralph  Hanson            |   |
|------------------------------|--------|
|                         |
| Ralph Hanson                 |
| Chief  Executive Officer and |
| Chief  Accounting Officer    |
| August 14,  2002             |

 

----
##### 



Exhibit 32.1

WFS FINANCIAL INC

CERTIFICATION OF CEO

In connection with the Annual Report of WFS
Financial Inc (the Company) on Form 10-K for
the year ended December 31, 2003 as filed with the
Securities and Exchange Commission on the date hereof (the
Report), the undersigned Chief Executive Officer of
the Company, hereby certifies, to the best of his knowledge and
belief and pursuant to 18 U.S.C., Chapter 63,
Section 1350, as adopted pursuant to Section 906 of
the SarbanesOxley Act of 2002, that:



|    |                                                                                                                                                            
|--- | -----------------------------------------------------------------------------------------------------------------------------------------------------------
|(1) | The Report fully complies with the requirements
    of Section 13(a) or 15(d) of the Securities and Exchange
    Act of 1934; and                          
|   
|(2) | The information contained in the Report fairly
    presents, in all material respects, the financial condition and
    result of operations of the Company.

The foregoing Certification is furnished solely
for purposes of complying with the provisions of
Section 906 of the Sarbanes-Oxley Act and is not intended
to be used for any other purpose.



|                  | 
|----------------- | 
|WFS FINANCIAL INC | 



|    |                     | 
|--- | ------------------- | 
|By: | /s/ THOMAS A. WOLFE | 

|                                                | 
|----------------------------------------------- | 
|                                                | 
|Thomas A. Wolfe                                 | 
|President, Chief Executive Officer and Director | 
|                                               
|Date: March 4, 2004                             |
Editorial Note on Part 112
Editorial Note: Nomenclature changes to part 112 appear at 81 FR 49896, July 29, 2016.

§ 112.153 What methods must I use to test spent sprout irrigation water (or sprouts) from each production batch of sprouts for pathogens to satisfy the requirements of § 112.144(b) and (c)? You must test spent sprout irrigation water (or sprouts) from each production batch for pathogens using: ( a ) For *E. coli* O157:H7, *Salmonella* species: ( 1 ) The method of analysis described in “Testing Methodologies for *E. coli* O157:H7 and *Salmonella* species in Spent Sprout Irrigation Water (or Sprouts),” Version 1, October 2015, U.S. Food and Drug Administration. The Director of the Federal Register approves this incorporation by reference in accordance with 5 U.S.C. 552(a) and 1 CFR part 5. You may obtain a copy from, and/or inspect a copy at, the Division of Produce Safety, Center for Food Safety and Applied Nutrition (CFSAN), Food and Drug Administration, 5001 Campus Dr., College Park, MD 20740, 240-402-1600; FDA's Main Library, 10903 New Hampshire Ave., Bldg. 2, Third Floor, Silver Spring, MD 20993, 301-796-2039; *http://www.fda.gov/fsma*; or at the National Archives and Records Administration (NARA). For information on the availability of this material at NARA, call 202-741-6030, or go to: *http://www.archives.gov/federal_register/code_of_federal_regulations/ibr_locations.html*; or
( 2 ) A scientifically valid method that is at least equivalent to the method of analysis in § 112.153(a)(1) in accuracy, precision, and sensitivity; and
( b ) For any other pathogen(s) meeting the criteria in § 112.144(c), a scientifically valid method.
Exhibit








                         Exhibit 10.2
Regulus Therapeutics Inc.
Timothy Wright, Ph.D. Yearly Discretionary Base Salary Increase


The Board of Directors (the “Board”) of Regulus Therapeutics Inc., upon the recommendation of the Compensation Committee of the Board, approved the increase of Dr. Wright’s annual base salary to $453,366, effective January 1, 2017.
irt-ex1010_444.htm



Exhibit 10.10

NOTICE OF AMENDMENT

Effective as of May 2, 2017

to the 

INDEPENDENCE REALTY TRUST, INC.
LONG TERM INCENTIVE PLAN

 

The Independence Realty Trust, Inc. Long Term Incentive Plan (the “Plan”) provides for a variety of compensatory awards to executives of Independence Realty Trust, Inc. (the “Company”).  You are receiving this notice because you have been granted an Award under the Plan that provides for payment in whole or in part through shares of Company stock.  

Under the terms of the Plan, when an Award becomes taxable to you, the Company may withhold a portion of the Company stock otherwise payable to you in order to pay Federal, state, local and payroll taxes owed by you in connection with the Award compensation.  The fair market value of the withheld Company stock is remitted to the appropriate taxing entity on your behalf and the balance is paid to you.  Prior to the amendment, the Plan provided that the Company would withhold the number of shares with an aggregate fair market value equal to the minimum estimated tax oblation.  

The Plan has been amended to require that the Company withhold the number of shares with an aggregate fair market value equal to the maximum estimated tax obligation. The withheld amount is still remitted to the appropriate taxing entity on your behalf and you are still paid the balance of your Award.  This change in withholding does not impact or otherwise diminish the pre-tax or after-tax value of your Award, nor does it change your overall all tax obligation.  Rather, the change will simply result in greater withholding that will reduce your tax payment obligation (or increase your refund) when you file your tax returns.

This change will be effective for withholding obligations under all Awards effective as of the date set forth above.
United States Court of Appeals

For the Eighth Circuit

___________________________

No. 20-1671

___________________________

Corey E. Fisherman

lllllllllllllllllllllPlaintiff - Appellant

v.

Jared McGriff, also known as Jered McGreiff; Bradley Dupre, M.D.; Kristin

Jacobs; Vicki Dean-Gramlich; Jack Serier

lllllllllllllllllllllDefendants - Appellees

Kristin, RN Pro M-H

lllllllllllllllllllllDefendant

 ____________

Appeal from United States District Court 

for the District of Minnesota

 ____________

 Submitted: December 21, 2020 

Filed: December 28, 2020

[Unpublished]

____________

Before GRUENDER, ERICKSON, and GRASZ, Circuit Judges. 

____________

PER CURIAM.
Corey Fisherman appeals following the district court’s1

 adverse grant of

summary judgment in his 42 U.S.C. § 1983 action. Having carefully reviewed the

record, we find no basis for reversal. See Odom v. Kaizer, 864 F.3d 920, 921 (8th

Cir. 2017) (grant of summary judgment is reviewed de novo); Carter v. Arkansas, 392

F.3d 965, 968 (8th Cir. 2004) (dismissal for failure to state a claim is reviewed de

novo). Accordingly, we affirm. See 8th Cir. R. 47B.

______________________________

1The Honorable Patrick J. Schiltz, United States District Judge for the District

of Minnesota, adopting the Report and Recommendation of the Honorable Elizabeth

Cowan Wright, United States Magistrate Judge for the District of Minnesota.

-2-
II 

Calendar No. 468 

118TH CONGRESS 

2D SESSION H. R. 7423 

IN THE SENATE OF THE UNITED STATES 

MAY 8, 2024 

Received; read twice and referred to the Committee on Homeland Security and 

Governmental Affairs 

AUGUST 1, 2024 

Reported by Mr. PETERS, without amendment 

AN ACT 

To designate the facility of the United States Postal Service 

located at 103 Benedette Street in Rayville, Louisiana, 

as the ‘‘Luke Letlow Post Office Building’’. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. LUKE LETLOW POST OFFICE BUILDING. 

4 (a) DESIGNATION.—The facility of the United States 

5 Postal Service located at 103 Benedette Street in Rayville, 

6 Louisiana, shall be known and designated as the ‘‘Luke 

7 Letlow Post Office Building’’. 


ssavage on LAPJG3WLY3PROD with BILLS
2 

•HR 7423 RS

1 (b) REFERENCES.—Any reference in a law, map, reg2 ulation, document, paper, or other record of the United 

3 States to the facility referred to in subsection (a) shall 

4 be deemed to be a reference to the ‘‘Luke Letlow Post 

5 Office Building’’. 


ssavage on LAPJG3WLY3PROD with BILLS

ssavage on LAPJG3WLY3PROD with BILLS
Calendar No. 468 

118TH CONGRESS 

2D SESSION H. R. 7423 

AN ACT 

To designate the facility of the United States PostOffice Building’’. Rayville, Louisiana, as the ‘‘Luke Letlow Post al Service located at 103 Benedette Street in 

AUGUST 1, 2024 

Reported without amendment 


ssavage on LAPJG3WLY3PROD with BILLS
I 

118TH CONGRESS 

2D SESSION H. R. 7473 

To ensure continued appropriations for certain Small Business Administration 

programs during a Government shutdown in fiscal year 2024, and for 

other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 28, 2024 

Mr. SCHIFF (for himself, Mr. THANEDAR, Mrs. FOUSHEE, and Mr. CASTRO

of Texas) introduced the following bill; which was referred to the Committee on Appropriations 

A BILL 

To ensure continued appropriations for certain Small Business Administration programs during a Government 

shutdown in fiscal year 2024, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Funding Small Busi5 nesses During Shutdown Act’’. 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
2 

•HR 7473 IH

1 SEC. 2. CONTINUATION OF CERTAIN SMALL BUSINESS AD2 MINISTRATION PROGRAMS DURING A GOV3 ERNMENT SHUTDOWN. 

4 There are appropriated for fiscal year 2024, out of 

5 any money in the Treasury not otherwise appropriated, 

6 during any period of a lapse in discretionary appropria7 tions with respect to the Small Business Administration 

8 during such fiscal year beginning on or after the date of 

9 the enactment of this section, for any 30-day period of 

10 such lapse (and on a pro-rated basis if such lapse is less 

11 than 30 days) to pay for the salaries and expenses nec12 essary to continue servicing any loans made under— 

13 (1) $500,000 for loans made under subsection 

14 (m) of section 7 of the Small Business Act (15 

15 U.S.C. 636(m)); 

16 (2) $2,916,666,667 for loans made under sub17 section (a) of section 7 of the Small Business Act 

18 (15 U.S.C. 636(a)); 

19 (3) $1,250,000,000 for loans made under title 

20 V of the Small Business Investment Act of 1958 (15 

21 U.S.C. 695 et seq.); and 

22 (4) $13,775,000 for administrative expenses to 

23 carry out the loan program under subsection (m) of 

24 section 7 of the Small Business Act (15 U.S.C. 

25 636(m)). 

Æ 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
IIB 

118TH CONGRESS 

2D SESSION H. R. 7423 

IN THE SENATE OF THE UNITED STATES 

MAY 8, 2024 

Received; read twice and referred to the Committee on Homeland Security and 

Governmental Affairs 

AN ACT 

To designate the facility of the United States Postal Service 

located at 103 Benedette Street in Rayville, Louisiana, 

as the ‘‘Luke Letlow Post Office Building’’. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
2 

HR 7423 RFS

1 SECTION 1. LUKE LETLOW POST OFFICE BUILDING. 

2 (a) DESIGNATION.—The facility of the United States 

3 Postal Service located at 103 Benedette Street in Rayville, 

4 Louisiana, shall be known and designated as the ‘‘Luke 

5 Letlow Post Office Building’’. 

6 (b) REFERENCES.—Any reference in a law, map, reg7 ulation, document, paper, or other record of the United 

8 States to the facility referred to in subsection (a) shall 

9 be deemed to be a reference to the ‘‘Luke Letlow Post 

10 Office Building’’. 

Passed the House of Representatives May 7, 2024. 

Attest: KEVIN F. MCCUMBER, 

Clerk. 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
THIS SCHEDULE  CONTAINS SUMMARY  FINANCIAL  INFORMATION  EXTRACTED FROM THE
QUARTERLY  REPORT 10-Q AND IS  QUALIFIED  IN ITS  ENTIRETY BY  REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
<CIK>                         0000813807
<NAME>                        COURTYARD BY MARRIOTT LIMITED PARTNERSHIP
<MULTIPLIER>                                   1,000
<CURRENCY>                                     U.S. DOLLAR
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                              DEC-31-1998
<PERIOD-START>                                 JAN-01-1998
<PERIOD-END>                                   SEP-11-1998
<EXCHANGE-RATE>                                1.00
<CASH>                                         7,234
<SECURITIES>                                   0
<RECEIVABLES>                                  4,314
<ALLOWANCES>                                   0
<INVENTORY>                                    0
<CURRENT-ASSETS>                               17,149
<PP&E>                                         543,002
<DEPRECIATION>                                 (239,582)
<TOTAL-ASSETS>                                 332,117
<CURRENT-LIABILITIES>                          41,276
<BONDS>                                        314,945
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<COMMON>                                       0
<OTHER-SE>                                     (24,104)
<TOTAL-LIABILITY-AND-EQUITY>                   332,117
<SALES>                                        0
<TOTAL-REVENUES>                               74,065
<CGS>                                          0
<TOTAL-COSTS>                                  0
<OTHER-EXPENSES>                               38,530
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             18,374
<INCOME-PRETAX>                                17,161
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            0
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   17,161
<EPS-PRIMARY>                                  0
<EPS-DILUTED>                                  0
        


</TABLE>
<TABLE> <S> <C>

<ARTICLE>          5
<LEGEND>           THIS SCHEDULE CONTAINS SUMMARY FINANCIAL
                   INFORMATION EXTRACTED FROM THE 
                   COMPANY'S UNAUDITED FINANCIAL STATEMENTS
                   AS OF AND FOR THE PERIOD ENDING MARCH 29, 
                   1997, AND IS QUALIFIED IN ITS ENTIRETY BY 
                   REFERENCE TO SUCH FINANCIAL STATEMENTS 
<MULTIPLIER>       1,000
<FISCAL-YEAR-END>  JAN-3-1998
<PERIOD-END>       MAR-29-1997
<PERIOD-TYPE>      3-MOS


<CASH>                                                  0
<SECURITIES>                                            0
<RECEIVABLES>                                     111,268
<ALLOWANCES>                                          530
<INVENTORY>                                        86,519
<CURRENT-ASSETS>                                  234,765
<PP&E>                                            181,563
<DEPRECIATION>                                     55,562
<TOTAL-ASSETS>                                    492,666
<CURRENT-LIABILITIES>                             194,778
<BONDS>                                                 0
<COMMON>                                           48,377
<PREFERRED-MANDATORY>                                   0
<PREFERRED>                                             0
<OTHER-SE>                                        199,108
<TOTAL-LIABILITY-AND-EQUITY>                      492,666
<SALES>                                           378,860
<TOTAL-REVENUES>                                  378,860
<CGS>                                             323,087
<TOTAL-COSTS>                                     323,087
<OTHER-EXPENSES>                                        0
<LOSS-PROVISION>                                        0
<INTEREST-EXPENSE>                                    414
<INCOME-PRETAX>                                    22,939
<INCOME-TAX>                                        9,100
<INCOME-CONTINUING>                                13,839
<DISCONTINUED>                                          0
<EXTRAORDINARY>                                         0
<CHANGES>                                               0
<NET-INCOME>                                       13,839
<EPS-PRIMARY>                                        0.28
<EPS-DILUTED>                                        0.28



</TABLE>
#### Racik Estate

*605
      *Raymond J. Porreca,*for exceptants.

*George Ovington, 3rd,*contra.

April 4, 1952.

Lefever, J.,

— This estate is before the court on exceptions: (1) To the refusal of the auditing judge to require the inclusion in the account of certain property owned by decedent and his widow as tenants by the entireties, and (2) to the allowance of the widow’s exemption. There is no need to repeat the facts which are accurately and clearly stated in the adjudication.

The written agreement between decedent and his widow is clear and unambiguous. Each agrees that the survivor will “will, devise and bequeath” one half of “their joint estate” to the children of the one first to die.

This is a common and natural form of agreement between a prospective or actual husband and wife, both of whom have children by former marriages. The parties clearly wished to accomplish two things thereby: (1) To place in the absolute and unfettered possession, control and disposal of the survivor all of their jointly owned property for his or her normal or emergency needs during his or her lifetime, and (2) to provide that whatever of their jointly owned property remained after the death of the survivor should be divided equally between their respective sets of children. The obligation of the survivor to the other’s children does not arise under this agreement until the survivor’s death. Therefore, the claim here brought is premature. If the parties had intended to create a trust of their jointly owned assets or otherwise to encumber them they could have easily and plainly done so. They did not do so. We should not defeat their manifest intent.

*606There is nothing in this *agreement to bar the*widow from her statutory exemption.* Exceptants have failed to meet the strong burden of proof placed upon them to show grounds for barring the widow from her exemption.

Accordingly, the exceptions are dismissed and the clear and carefully written adjudication of the learned auditing judge is made absolute.

The amount of the widow’s exemption has been set at $500, inasmuch as this is the amount claimed by the widow and accordingly allowed by the court.
§ 522.480 Corticotropin. ( a ) *Specifications.* Each milliliter of aqueous solution contains 40 or 80 U.S.P. (I.U.) units of repository corticotropin.
( b ) *Sponsor.* See sponsors in § 510.600(c) of this chapter. ( 1 ) No. 061133 for use as in paragraphs (c)(1) and (2) of this section.
( 2 ) No. 043264 for use as in paragraph (c)(2) and (3) of this section.
( c ) *Conditions of use* — ( 1 ) *Dogs* — ( i ) *Amount.* Administer one unit per pound of body weight by intramuscular injection.
( ii ) *Indications for use.* As a diagnostic aid to test for adrenal dysfunction.
( iii ) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.
( 2 ) *Dogs and cats* — ( i ) *Amount.* Administer one unit per pound of body weight by intramuscular or subcutaneous injection, to be repeated as indicated.
( ii ) *Indications for use.* For stimulation of the adrenal cortex where there is a general deficiency of corticotropin (ACTH).
( iii ) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.
( 3 ) *Cattle* — ( i ) *Amount.* Administer 200 to 600 units by intramuscular or subcutaneous injection as an initial dose, followed by a dose daily or every other day of 200 to 300 units.
( ii ) *Indications for use.* As a therapeutic agent for primary bovine ketosis; and for stimulation of the adrenal cortex where there is a general deficiency of ACTH.
( iii ) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[79 FR 16185, Mar. 25, 2014, as amended at 84 FR 8973, Mar. 13, 2019; 85 FR 45308, July 28, 2020]
Exhibit 23.1

Consent of Independent Registered Accounting Firm

We
consent to the use of our report dated June 27, 2008, with respect to the financial statements of Digital Link II, LLC included in Form 10-K/A and incorporated by reference in the
registration statement No. 333-139177 on Form S-8, No. 333-116739 on Form S-8 and No.  333-03849 on Form S-8 of Ballantyne of Omaha, Inc.

|                                      |  | /s/ ERNST & YOUNG, LLP
|------------------------------------- |  | ----------------------
|Los Angeles, California
June 27, 2008 |  |                       

---



QuickLinks
### Geohydrology and water resources of the Tucson basin, Arizona

By: Edward Sheldon Davidson

                            https://doi.org/10.3133/wsp1939E

#### Links

-                                                                                                                             Document:                                                                                                                                                                                                                                                  **Report**                                                                                                     (pdf)                                                                                                                                     
- Plates:                               - **Plate 1**                            (pdf)
  - **Plate 2**                            (pdf)
  - **Plate 3**                            (pdf)
  - **Plate 4**                            (pdf)
  - **Plate 5**                            (pdf)
  - **Plate 6**                            (pdf)
  - **Plate 7**                            (pdf) 
- NGMDB Index Page:  **National Geologic Map Database Index Page**                            (html)
- Download citation as:  RIS                         |                         Dublin                            Core

#### Abstract

No abstract available.

#### Study Area

Part or all of this report is presented in Portable Document Format                        (PDF). For best results viewing and printing PDF documents, it is recommended that you download                        the documents to your computer and open them with Adobe Reader. PDF documents opened from your                        browser may not display or print as intended. Download the latest version of Adobe Reader, free of charge. More information                        about viewing, downloading, and printing report files can be found at the common download problems FAQ.